Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization

Pavel Dundr, Michal Mára, Jana Mašková, Jana Masková, Zuzana Fucíková, Z Fucíková, Ctibor Povỳsil, C Povýšil, Daniel Tvrdík
Pathology, research and practice · 2006 · vol. 202(10) , pp. 721–729 · doi:10.1016/j.prp.2006.07.001 · PMID:16959435 · W2045501291
article OA: closed CC0 ⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper describes the pathological findings of uterine leiomyomas and adenomyosis after uterine artery embolization.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Embolization, Therapeutic Endometriosis Leiomyoma Uterine Neoplasms Uterus Adult Arteries Endometriosis Endometriosis Female Gelatin Gelatin Humans Leiomyoma Leiomyoma Middle Aged Necrosis Polyvinyl Alcohol Polyvinyl Alcohol Prospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (8)

Source provenance

europepmc
last seen: 2026-06-17T06:13:18.893374+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
unpaywall
last seen: 2026-06-17T06:32:23.968882+00:00
License: CC0 · commercial use OK